Although N-linked glycans play pivotal roles in the regulation of antibody effector functions, little is known about the composition and functional impact of glycans attached to human B cell receptors (BCR). Here, we describe the site-specific glycosylation profiles of all 4 N-linked glycosylation sites of human Igµ BCRs from primary naive and memory B cells. Our data indicate that the Igµ BCR glycans do not undergo structural changes during transition from naive to memory cells, as healthy donor-derived BCRs from both B cell subtypes carry similar glycans. Conversely, serum IgM antibodies display distinct glycosylation features to Igµ BCRs, which are in part explained by the different molecular form of Igµ BCRs and IgM antibodies. Moreover, using B cell lines expressing defined BCRs, we show that, although the absence of the Igµ BCR N209 glycans reduces antigen binding, the individual glycosylation sites are nonessential for cell surface expression and BCR internalization following BCR triggering. Collectively, we show high conservation of Igµ BCR glycosylation across B cell subsets and limited contribution to BCR expression and function, suggesting BCR glycans may have evolved to support IgM antibody functions.
Immunoglobulin G (IgG) is a glycoprotein harboring conserved fragment crystallizable domain glycans, but it can also express variable domain glycans (VDGs). Elevated levels of VDGs are a hallmark of the autoantibodies most specific to rheumatoid arthritis and are also associated with other autoimmune diseases. Nonetheless, the effect of VDGs on IgG function remains poorly understood. This study investigates the impact of VDGs on the ability of antibodies to activate the complement system, a key immune effector mechanism. We demonstrate that VDGs on IgG inhibit the initiation of the classical complement pathway, as evidenced by complement activation assays with IgG displaying varying degrees of VDGs. Structure–function analyses show that VDGs reduce classical complement activation by impeding IgG oligomer formation on antigenic surfaces. As IgG oligomerization is essential for effective C1q binding, VDG-mediated interference with this process lowers IgG's complement activation potential. This impaired ability to recruit complement was further substantiated through direct visualization of IgG oligomer–C1q complexes on antigen-coated vesicles by cryoelectron tomography. Together, these data reveal that VDGs increase the functional diversity of IgG and identify a novel regulatory mechanism that modulates the ability of antibodies to activate one of their main immune effector mechanisms.